Atlas Wealth’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$214K Buy
+14,471
New +$104K 0.03% 169

Other funds holding IOVA

Atlas Wealth's IOVA Position: Q3 2026 in Review

Atlas Wealth opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2026: 14,471 shares worth $214K. The stake represents 0.03% of the portfolio and ranks #169 among its holdings.

334 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • Atlas Wealth held 14,471 shares of Iovance Biotherapeutics worth $214K as of Q3 2026.
  • Iovance Biotherapeutics was a new Atlas Wealth position in Q3 2026.
  • Iovance Biotherapeutics made up 0.03% of Atlas Wealth's portfolio in Q3 2026, its #169 holding.
  • 334 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on Atlas Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.